Thurston, Springer, Miller, Herd & Titak, Inc. Viatris Inc Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 790 shares of VTRS stock, worth $8,579. This represents 0.0% of its overall portfolio holdings.
Number of Shares
790
Previous 2,254
64.95%
Holding current value
$8,579
Previous $26,000
65.38%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding VTRS
# of Institutions
1,130Shares Held
986MCall Options Held
2.34MPut Options Held
2.21M-
Vanguard Group Inc Valley Forge, PA142MShares$1.54 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.01 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.7MShares$692 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$680 Million4.62% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD58.7MShares$637 Million0.08% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...